Overview
Darren Cross practices in Cambridge, United Kingdom. Mr. Cross is rated as an Advanced expert by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.
His clinical research consists of co-authoring 36 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of EGFR Positive Lung Cancer.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung CancerMr. Cross isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung CancerMr. Cross isAdvanced. Learn about Lung Cancer.
- Experienced
- AstrocytomaMr. Cross isExperienced. Learn about Astrocytoma.
- EpilepsyMr. Cross isExperienced. Learn about Epilepsy.
- GlioblastomaMr. Cross isExperienced. Learn about Glioblastoma.
- Lung AdenocarcinomaMr. Cross isExperienced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Cross isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).